Crossmark Global Holdings’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$243K Buy
2,466
+58
+2% +$5.71K ﹤0.01% 1190
2025
Q1
$223K Sell
2,408
-27
-1% -$2.5K ﹤0.01% 1219
2024
Q4
$222K Sell
2,435
-79
-3% -$7.2K ﹤0.01% 1168
2024
Q3
$243K Buy
+2,514
New +$243K ﹤0.01% 1163
2024
Q2
Sell
-2,427
Closed -$223K 1296
2024
Q1
$223K Sell
2,427
-99
-4% -$9.1K ﹤0.01% 1237
2023
Q4
$240K Buy
2,526
+28
+1% +$2.66K 0.01% 1180
2023
Q3
$231K Sell
2,498
-9
-0.4% -$832 0.01% 1143
2023
Q2
$227K Sell
2,507
-355
-12% -$32.1K ﹤0.01% 1198
2023
Q1
$210K Buy
2,862
+373
+15% +$27.4K ﹤0.01% 1206
2022
Q4
$208K Sell
2,489
-264
-10% -$22.1K 0.01% 1186
2022
Q3
$266K Buy
2,753
+24
+0.9% +$2.32K 0.01% 1044
2022
Q2
$287K Sell
2,729
-60
-2% -$6.31K 0.01% 1047
2022
Q1
$480K Sell
2,789
-130
-4% -$22.4K 0.01% 916
2021
Q4
$473K Sell
2,919
-1,010
-26% -$164K 0.01% 915
2021
Q3
$586K Sell
3,929
-140
-3% -$20.9K 0.01% 845
2021
Q2
$997K Sell
4,069
-280
-6% -$68.6K 0.02% 612
2021
Q1
$1.15M Buy
4,349
+100
+2% +$26.5K 0.03% 547
2020
Q4
$1.25M Buy
4,249
+550
+15% +$161K 0.03% 508
2020
Q3
$875K Sell
3,699
-40
-1% -$9.46K 0.02% 577
2020
Q2
$742K Buy
3,739
+420
+13% +$83.3K 0.02% 624
2020
Q1
$609K Sell
3,319
-110
-3% -$20.2K 0.02% 595
2019
Q4
$572K Sell
3,429
-1,640
-32% -$274K 0.02% 738
2019
Q3
$664K Sell
5,069
-20
-0.4% -$2.62K 0.02% 673
2019
Q2
$618K Sell
5,089
-520
-9% -$63.1K 0.02% 722
2019
Q1
$691K Buy
5,609
+10
+0.2% +$1.23K 0.02% 664
2018
Q4
$656K Sell
5,599
-3,490
-38% -$409K 0.02% 650
2018
Q3
$1.14M Sell
9,089
-440
-5% -$55K 0.03% 554
2018
Q2
$814K Buy
9,529
+400
+4% +$34.2K 0.02% 691
2018
Q1
$551K Sell
9,129
-800
-8% -$48.3K 0.01% 856
2017
Q4
$523K Buy
9,929
+3,830
+63% +$202K 0.01% 962
2017
Q3
$341K Buy
+6,099
New +$341K 0.01% 1227
2016
Q3
$341K Buy
+6,099
New +$341K 0.01% 1227